Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing - Concepedia

Concepedia

Publication | Open Access

Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing

DOI Full Paper Access

33

Citations

34

References

2020

Year

Li Li, Lan Deng, Xiaoqing Meng, Changling Gu, Meng Li, Kai Li, Xuesai Zhang, Yun Meng, Wei Xu, Le Zhao,

Translational Oncology

References

	Year	Citations

Page 1